Candice du Fretay, a former investor at global VC powerhouse Accel, has launched Outlier Grove, a $20 million solo GP
Bringing a new drug to market takes 10–15 years and costs €1.5–2 billion, with a clinical trial failure rate of
German unicorn Enpal, known for supplying green energy tech like solar panels and batteries to households, has raised €110 million
Private capital firms manage trillions in assets, yet their operating model remains stuck with tools not built for the purpose.
Anecdotes, claimed to be the only data-driven Governance, Risk, and Compliance (GRC) platform tailored for enterprise operations, has closed the
Liberation Day, as President Trump termed it, has not been welcomed as a liberation by most other people. The markets
Traditional knee replacements often fail in younger patients due to implant loosening and poor long-term fixation from surgical cement. These
The insurance industry is heading toward a risk engineering cliff. With 40% of risk engineers retiring within the next five
Cyber-attacks are becoming more severe, frequent, and complex. One study identified them as the greatest global risk for 2025. The
Ravi Yatnalkar’s journey into entrepreneurship didn’t start in a startup accelerator—it started in a family kitchen. Coming from a catering